DIPEXIUM PHARMACEUTICALS INC - COM (DPRX)

CUSIP: 25456J104

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
1,764,738
Share change
-301,944
Total reported value
$17,047,000
Price per share
$9.70
Number of holders
15
Value change
-$2,933,451
Number of buys
8
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 25456J104?
CUSIP 25456J104 identifies DPRX - DIPEXIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) as of Q2 2014

As of 30 Jun 2014, DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,764,738 shares. The largest 10 holders included KINGDON CAPITAL MANAGEMENT, L.L.C., Broadfin Capital, LLC, Pine River Capital Management L.P., Timpani Capital Management LLC, GREAT POINT PARTNERS LLC, SPHERA FUNDS MANAGEMENT LTD., OPPENHEIMER & CO INC, Tower Research Capital LLC, DEUTSCHE BANK AG\, and Ground Swell Capital, LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.